QIAGEN N.V. (QGEN)
QIAGEN N.V. is a global provider of sample and assay technologies, serving the life sciences and molecular diagnostics markets. The company specializes in sample preparation, gene detection, and bioinformatics solutions designed for research, clinical, and molecular testing applications. QIAGEN's products facilitate the analysis of biological samples to detect, diagnose, and monitor diseases, making it a key player in advancing personalized healthcare and molecular diagnostics.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| $1.26 | 2025-01-29 | ||
| $1.04 | 2017-01-25 | ||
| July 10, 2025 | $0.25 | 2025-07-02 | 2025-07-02 |
Dividends Summary
- The most recent dividend was paid 72 days ago, on July 10, 2025
- The highest dividend payed out to investors during this period was $1.26 per share
- The average dividend paid during this period was $0.85 per share.
Company News
The Automated Microbiology Market is projected to grow from $7.87 billion in 2025 to $12.52 billion by 2030, with a 9.74% CAGR, driven by demand for efficient diagnostic solutions in healthcare and industrial sectors.
The global sample preparation market is expected to grow at a CAGR of 6.4% by 2031, driven by technological advancements in specimen collection and preparation. The consumables segment and solid-phase extraction technique are expected to lead the market growth.
Hologic, a women's health-focused diagnostics company, is set to report its fiscal 2024 third-quarter results. The performance is expected to reflect the strength of the company's core franchises, overcoming the challenging comparisons of fiscal 2023. The company's broad menu of molecular diagnostics tests, excluding COVID-19 assays, and strong performance in its Breast Health and GYN Surgical segments are likely to drive growth.
Stay updated on Wall Street news with our daily podcast available on Seeking Alpha, iTunes, and Spotify.
The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more — and there may not be one.
